Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Yinshan Lin

State Key Laboratory of Respiratory Disease

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · JOURNAL ARTICLE

Antagonistic peptide-displayed artificial exosome carrying PROTAC for the synergistic lung cancer therapy

Journal of Nanobiotechnology

Preclinical in vivo study in animal models demonstrating a novel nanoparticle-PROTAC combination system; no human clinical data, efficacy compared only to implied controls, and lacks direct comparison to standard therapies.

PreliminaryQiuyun Liu Protein Degradation and Inhibitors Yinshan Lin

Reported

BRD4 protein degradation89.2 ± 3.7%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support